Delivery Order SPE2DB20D9226-SPE2DB24FQ58C
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, a firm fixed-price delivery order valued at $34,689.57, covers the supply of pharmaceutical products such as Alecensa 150 mg capsules to support the recurring medical needs of military health facilities worldwide. The contract is part of a larger indefinite delivery contract (IDC) valued...
- This federal contract award, valued at $25,564.66, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Alecensa 150 mg capsules, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,047.88, is for the delivery of the pharmaceutical product Alecensa 150 mg capsules. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $24,948.60 and a period of performance through June 5, 2024. Under this contract, DMS Pharmaceutical Group will provide a branded pharmaceutical product, Alecensa 150 mg capsules, to support the recurring medical supply needs of military health...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,474.29, is for the supply of 4,564,014,996 units of the medication Alecensa 150 mg capsules. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
- The federal contract award SPE2DB20D9226|SPE2DB25FQ55X was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,474.29 firm fixed-price delivery order is for the supply of 4566278255 Alecensa 150 mg capsules. This award is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to place orders for a...
- The federal contract award SPE2DX15D9168 was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $96,383.04 firm fixed-price delivery order is for the supply of the prescription drug Alecensa 150 mg capsules, with a completion date of February 10, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,474.29 firm fixed-price delivery order is for the supply of 4566435319 Alecensa 150 mg capsules. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $69,379.14 firm fixed-price delivery order (SPE2DB20D9226) is for the supply of 240 capsules of the drug Alecensa (150 mg) to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (SPE2DB23FQ56K) valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $12,474.29 firm fixed-price delivery order contract is for the supply of Alecensa 150 mg capsules. The award is part of a larger indefinite delivery vehicle (IDV) contract, valued at up to $4,999,999, that DMS Pharmaceutical Group Inc. holds with the DLA under the SPE2DB program. This single-award IDV enables...
- SPE2DB20D9226Indefinite Delivery Contract
- SPE2DB20D9226-SPE2DB24FQ58CDelivery Order
This federal contract award, with ID SPE2DB20D9226 and SPE2DB24FQ58C, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,474.29 firm fixed-price delivery order is for the supply of Alecensa 150 mg capsules, among other pharmaceutical products, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to fulfill the diverse medical requirements of Department of Defense (DoD) healthcare facilities. This contract has no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 2/26/24 |